Inipharm is a biopharmaceutical company that develops treatments for severe liver diseases. It is building on novel insights into the biologic activity of HSD17B13 gene. The company aims to advance a collection of potent and selective small molecules that mimic the protective phenotype.
|HQ||Bellevue, WA, US||Map|
Inipharm total Funding
Inipharm latest funding size
Time since last funding
|7 months ago|
|5AM Ventures, Frazier Healthcare Partners, Wu Capital, Jubilant Biosys Limited|
When was Inipharm founded?
Inipharm was founded in 2018.
Who are Inipharm key executives?
Inipharm's key executives are Brian Farmer, Mike Gallatin and Heather Hsu.
Who are Inipharm competitors?
Competitors of Inipharm include ReviveMed, ALX Oncology and Sosei Heptares.
Where is Inipharm headquarters?
Inipharm headquarters is located at 500 108th Ave NE #1100, Bellevue.
Where are Inipharm offices?
Inipharm has offices in Bellevue and San Diego.
How many offices does Inipharm have?
Inipharm has 2 offices.
Receive alerts for 300+ data fields across thousands of companies